Open access
Aug 2026
Engineered human iPSC-derived dendritic cells dressed with tumor MHC complexes as a cancer vaccine.
PD-L1/2-null TumorDressed DCs demonstrate robust priming of anti-tumor T cell-mediated cytotoxicity both in vitro and in vivo, including against primary hematologic and solid tumors with matching patient T cells.
Huaigeng Xu, Chisato Kamei, Deniz Gökbuget et al.
· Cell Stem Cell · 0 citations